Your browser doesn't support javascript.
loading
Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goal.
Ji, Lanlan; Gao, Dai; Hao, Yanjie; Huang, Hong; Wang, Yu; Deng, Xuerong; Geng, Yan; Zhang, Zhuoli.
Afiliación
  • Ji L; Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China.
  • Gao D; Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China.
  • Hao Y; Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China.
  • Huang H; Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China.
  • Wang Y; Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China.
  • Deng X; Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China.
  • Geng Y; Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China.
  • Zhang Z; Rheumatology and Immunology Department, Peking University First Hospital, Beijing, China.
Rheumatology (Oxford) ; 62(1): 181-189, 2022 12 23.
Article en En | MEDLINE | ID: mdl-35412598
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucocorticoides / Lupus Eritematoso Sistémico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucocorticoides / Lupus Eritematoso Sistémico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China